Misoprostol is a synthetic prostaglandin E 1 analogue that is used off-label for a variety of
indications in the practice of obstetrics and gynecology, including medication abortion …

Induced abortion is still a major health problem in the world and the most frequently
performed intervention in obstetrics and gynecology with an estimated total of 46 million …

Background Postpartum haemorrhage is a major cause of maternal mortality in the
developing world. Although effective methods for prevention and treatment of such …

Background Labour induction should be performed where benefit outweighs potential harm,
however epidemiology of induction in lower-income countries is not well described. We …

O tratamento das complicações do aborto provocado pode ser dificultado por atitudes de
discriminação praticadas por profissionais de saúde nos hospitais e serviços de aborto …

Despite the strong interest of international health agencies, worldwide maternal mortality
has not declined substantially over the past 10 years. Postpartum hemorrhage (PPH) is the …

Objectives: Determine safety of household management of postpartum hemorrhage (PPH)
with 1000 μg of rectal misoprostol, and assess possible reduction in referrals and the need …

Objective To validate anecdotal reports that abortion‐related complications decreased in the
Dominican Republic after the introduction of misoprostol into the country. Design …

Objective. To compare the efficacy of two different medical treatment regimens: mifepristone
600 mg orally+ misoprostol 0.4 mg vaginally (Mf+ Ms) or misoprostol 0.4 mg vaginally (Ms) …

OBJECTIVE: To assess the worldwide availability of misoprostol. Documenting the extent of
misoprostol use in obstetrics-gynecology is difficult because the drug typically is …